New Cancer Surgical Tech Gets Positive Vote, But Some Cite Safety ConcernsMarch 8, 2024Breast CancerPatient & Survivor CarePractice ManagementMetastatic Breast CancerPreventive Care
Nivolumab Wins First-Line Indication in Metastatic Urothelial CarcinomaMarch 8, 2024Genitourinary CancerPatient & Survivor CarePractice ManagementMixed Topics
TIL for Melanoma: What Are the Costs and Other Challenges to Getting It to Patients?March 8, 2024MelanomaImmunotherapyImmuno-oncologyPatient & Survivor CarePractice ManagementMixed Topics
Medicare Pay Bump Provision in Federal Bill Falls Short, Doc Groups SayMarch 7, 2024Practice Management
Outside the Guidelines: Denosumab Overuse in Prostate CancerMarch 4, 2024Genitourinary CancerPractice Management
FDA Removes Harmful Chemicals From Food PackagingMarch 1, 2024Mixed TopicsPediatricsBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
Receiving Unfair Negative Patient Reviews Online? These Apps Pledge ReliefFebruary 29, 2024Practice Management
FDA Withdraws Melflufen Approval, but EMA Still Allows Its UseFebruary 29, 2024Patient & Survivor CarePractice Management
Poor Quality of Cancer Content on Social MediaFebruary 23, 2024Gynecologic CancerPatient & Survivor CarePreventive CareDiversity in MedicinePractice Management
